News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Inside the Seattle labs of Xaira, the AI-powered startup launched with $1B from investors
Xaira Therapeutics – a spinout from the University of Washington’s Institute for Protein Design (IPD) – merges AI with science to create generative models for
Sana CEO outlines growth plans after opening Bothell facility
Headquartered in Seattle, Sana Biotechnology opened its new 80,000 square-foot manufacturing facility in Bothell, Washington, which will house Sana’s proprietary cancer drug program. Sana utilizes
AGC Biologics’ Seattle Site Achieves Successful Multi-Product Inspection by U.S. Food and Drug Administration for Biologics License Applications
AGC Biologics, a Seattle-based biomanufacturer, announced that its Seattle campus achieved a new milestone for regulatory compliance in partnership with the Food and Drug Administration
Protein design startup Outpace lands $144M to test treatments targeting solid tumors
Outpace Bio, a Seattle-based startup using AI to design proteins for cancer therapies targeting solid tumors, has secured $144 million in new funding from investors.
UW lands $50M from National Science Foundation to lead new center for research security
The University of Washington has been awarded a $50 million grant from the National Science Foundation to spearhead the Safeguarding the Entire Community of the
Kirkland biotech company raises $196M for wearable defibrillator
Kestra Medical Technologies, a Kirkland-based biotechnology company specializing in wearable defibrillators, has raised $196 million in its latest funding round. In a recent release, CEO
Top 10 U.S. Biopharma Clusters 2024
Seattle and the Greater Puget Sound continue to rank among the top biopharma clusters in the U.S., securing the #10 spot this year. GEN’s four
Allen Institute for AI’s new office lease bolsters an emerging artificial intelligence corridor in Seattle
The Allen Institute for AI (AI2) has leased a full floor in the Northlake Commons building, encompassing 50,000 square feet. Founded by the late Microsoft
Executive Insights: Cultivating Unity, Growth, and Improved Patient Outcomes through Diverse Team Experiences
Ann Houseman, Vice President and Cell Therapy Site Leader at Bristol Myers Squibb (BMS) in Bothell, Washington, shares her perspective on the importance of diverse
Seattle biotech startup Bonum upgrades offices, expands team in its pursuit of cancer drugs
Bonum Therapeutics, a Seattle-based biomanufacturer, is moving into new offices in South Lake Union and plans to double its workforce in pursuit of producing its
Genome recording makes living cells their own historians
The University of Washington School of Medicine has developed the capability for genomes to store information in real-time about a variety of biological events inside
Catching up with WSU’s Steve Gleason Institute
The Steve Gleason Institute has become a leading treatment center for neurodegenerative diseases in the Pacific Northwest. Named after former Washington State University and New